{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T06:41:41Z","timestamp":1694155301173},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.endonu.2010.10.011","type":"journal-article","created":{"date-parts":[[2011,2,21]],"date-time":"2011-02-21T20:28:02Z","timestamp":1298320082000},"page":"84-89","source":"Crossref","is-referenced-by-count":1,"title":["A prop\u00f3sito de un caso de neoplasia endocrina m\u00faltiple tipo 1. Revisi\u00f3n de algunas manifestaciones cl\u00ednicas y controversias en el tratamiento"],"prefix":"10.1016","volume":"58","author":[{"given":"Cristina","family":"Familiar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Ant\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Moraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Araceli","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endonu.2010.10.011_bib0005","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jc.86.12.5658","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2010.10.011_bib0010","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.sla.0000143252.02142.3e","article-title":"Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison Syndrome","volume":"240","author":"Norton","year":"2004","journal-title":"Ann Surg."},{"key":"10.1016\/j.endonu.2010.10.011_bib0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00005792-199701000-00002","article-title":"Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1","volume":"76","author":"Teh","year":"1997","journal-title":"Medicine."},{"key":"10.1016\/j.endonu.2010.10.011_bib0020","first-page":"273","article-title":"Pathogenesis of ECL cell tumors in humans","volume":"71","author":"Bordi","year":"1998","journal-title":"Yale J Biol Med."},{"key":"10.1016\/j.endonu.2010.10.011_bib0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s002689900027","article-title":"Management of carcinoids tumors of the stomach, duodenum and pancreas","volume":"20","author":"Akerstrom","year":"1996","journal-title":"W J Surg."},{"key":"10.1016\/j.endonu.2010.10.011_bib0030","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/gut.33.9.1275","article-title":"Influence of multiple endocrine type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome","volume":"33","author":"Lehy","year":"1992","journal-title":"Gut."},{"key":"10.1016\/j.endonu.2010.10.011_bib0035","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/0016-5085(93)90736-V","article-title":"Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome","volume":"105","author":"Cadiot","year":"1993","journal-title":"Gastroenterology."},{"key":"10.1016\/j.endonu.2010.10.011_bib0040","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00268-002-6492-4","article-title":"Adrenal involvement in multiple endocrine neoplasia type 1","volume":"8","author":"Langer","year":"2002","journal-title":"W J Surg."},{"key":"10.1016\/j.endonu.2010.10.011_bib0045","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archderm.1997.03890430067009","article-title":"Multiple facial angiofibroma and collagenomas in patients with multiple endocrine type 1 neoplasia","volume":"133","author":"Darling","year":"1997","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.endonu.2010.10.011_bib0050","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-129-6-199809150-00011","article-title":"Clinical expressions of multiple endocrine neoplasia type 1 at the National Institutes of Health","volume":"129","author":"Skarulis","year":"1998","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.endonu.2010.10.011_bib0055","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/archsurg.133.2.126","article-title":"The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1","volume":"133","author":"Burgess","year":"1998","journal-title":"Arch Surg."},{"key":"10.1016\/j.endonu.2010.10.011_bib0060","series-title":"The metabolic and molecular bases of inherited disease","first-page":"943","article-title":"Multiple endocrine neoplasia type 1","author":"Marx","year":"2001"},{"key":"10.1016\/j.endonu.2010.10.011_bib0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2796.2004.01428.x","article-title":"Parathyroid surgery in familial hyperparathyroid disorders","volume":"257","author":"Carling","year":"2005","journal-title":"J Intern Med."},{"key":"10.1016\/j.endonu.2010.10.011_bib0070","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/SLA.0b013e31811f4467","article-title":"Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1","volume":"246","author":"Tonelli","year":"2007","journal-title":"Ann Surg."},{"key":"10.1016\/j.endonu.2010.10.011_bib0075","first-page":"998","article-title":"Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach","volume":"110","author":"Demeure","year":"1991","journal-title":"Surgery."},{"key":"10.1016\/j.endonu.2010.10.011_bib0080","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/BF00353743","article-title":"Surgical management of insulinoma associated with multiple endocrine neoplasia type 1","volume":"18","author":"O\u2019Riordan","year":"1994","journal-title":"World J Surg."},{"key":"10.1016\/j.endonu.2010.10.011_bib0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/jcem-73-2-281","article-title":"Multiple endocrine neoplasi type 1: a 10-year prospective screening study in four kindreds","volume":"73","author":"Skogseid","year":"1991","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2010.10.011_bib0090","doi-asserted-by":"crossref","unstructured":"Lairmore TC, Chen VY, DeBenedetti MK, Gillanders WE, Norton JA, Doherty GM. Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg. 2000;23:909\u201318.","DOI":"10.1097\/00000658-200006000-00016"},{"key":"10.1016\/j.endonu.2010.10.011_bib0095","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00006676-199305000-00003","article-title":"Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type 1 multiple endocrine neoplasia","volume":"8","author":"Rusniewski","year":"1993","journal-title":"Pancreas."},{"key":"10.1016\/j.endonu.2010.10.011_bib0100","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0016-5085(89)91485-6","article-title":"Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study","volume":"97","author":"Maton","year":"1989","journal-title":"Gastroeneterology."},{"key":"10.1016\/j.endonu.2010.10.011_bib0105","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1200\/JCO.2001.19.12.3051","article-title":"Prognostic value of initial fasting serum gastrin levels in patients with Zollinger-Ellison syndrome","author":"Berger","year":"2001","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.endonu.2010.10.011_bib0110","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0016-5085(95)90124-8","article-title":"Determinants of metastatic rate and supervival in patients with Zollinger-Ellison syndrome: a prospective long-term study","volume":"108","author":"Weber","year":"1995","journal-title":"Gastroenterology."},{"key":"10.1016\/j.endonu.2010.10.011_bib0115","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1200\/JCO.1999.17.2.615","article-title":"Prospective study of the clinical course; prognostic factors, causes of death and survival in patientes with long-standing Zollinger-Elllison syndrome","volume":"17","author":"Yu","year":"1999","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.endonu.2010.10.011_bib0120","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199908263410902","article-title":"Surgery to cure the Zoolinger-Ellison syndrome","volume":"341","author":"Norton","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1016\/j.endonu.2010.10.011_bib0125","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00000658-199409000-00008","article-title":"Surgery in Zollinger-Ellison Syndrome alters the natural history of gastrinoma","volume":"220","author":"Fraker","year":"1994","journal-title":"Ann Surg."},{"key":"10.1016\/j.endonu.2010.10.011_bib0130","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/01.sla.0000234802.44320.a5","article-title":"Surgery increases survival in patients with gastrinoma","volume":"244","author":"Norton","year":"2006","journal-title":"Ann Surg."},{"key":"10.1016\/j.endonu.2010.10.011_bib0135","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00000658-200110000-00009","article-title":"Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome","volume":"234","author":"Norton","year":"2001","journal-title":"Ann Surg."},{"key":"10.1016\/j.endonu.2010.10.011_bib0140","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/BF02067341","article-title":"Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes","volume":"16","author":"Grama","year":"1992","journal-title":"World J Surg."},{"key":"10.1016\/j.endonu.2010.10.011_bib0145","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJM199003153221103","article-title":"Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger- Ellison syndrome","volume":"322","author":"Pipeleers-Marichal","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1016\/j.endonu.2010.10.011_bib0150","first-page":"1249","article-title":"Diagnostic and therapeutic strategies in Zollinger-Ellison syndrome associated with multiple endocrine neoplasia type I (MEN-I): experience of the Zollinger-Ellison Syndrome Research Group: Bichat 1958\u20131999","volume":"187","author":"Mignon","year":"2003","journal-title":"Bull Acad Natl Med."},{"key":"10.1016\/j.endonu.2010.10.011_bib0155","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00000658-199308000-00004","article-title":"A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas","volume":"218","author":"Sugg","year":"1993","journal-title":"Ann Surg."},{"key":"10.1016\/j.endonu.2010.10.011_bib0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000098009","article-title":"Gastrinoma (duodenal and pancreatic)","volume":"84","author":"Jensen","year":"2006","journal-title":"Neuroendocrinology."},{"key":"10.1016\/j.endonu.2010.10.011_bib0165","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1097\/00000478-199611000-00009","article-title":"Inmunohistochemical study of 100 pancraetic tunors in 28 patients with multiple endocrine neoplasia type 1","volume":"20","author":"Le Bodic","year":"1996","journal-title":"Am J Surg Pathol."},{"key":"10.1016\/j.endonu.2010.10.011_bib0170","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1067\/S0016-5107(03)01965-5","article-title":"EUS detection of pancreatic endocrine tumors in asymptomatic patients with type 1 multiple endocrine neoplasia","volume":"58","author":"Wamsteker","year":"2003","journal-title":"Gastrointes Endosc."},{"key":"10.1016\/j.endonu.2010.10.011_bib0175","first-page":"495","article-title":"Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic- duodenal disease","volume":"243","author":"Thompsom","year":"1998","journal-title":"Results in the treatment of 40 patients with the Zollinger. Ellison syndrome, hypoglycaemia or both. J Intern Med."},{"key":"10.1016\/j.endonu.2010.10.011_bib0180","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1067\/msy.2000.109727","article-title":"Pancetaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance?","volume":"128","author":"Bartsh","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.endonu.2010.10.011_bib0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.sla.0000218073.77254.62","article-title":"Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias","volume":"244","author":"Tonelli","year":"2006","journal-title":"Ann Surg."},{"key":"10.1016\/j.endonu.2010.10.011_bib0190","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0016-5085(99)70124-1","article-title":"Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type","volume":"116","author":"Cadiot","year":"1999","journal-title":"Gastroenterology."},{"key":"10.1016\/j.endonu.2010.10.011_bib0195","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s002689900438","article-title":"Lethality of multiple endocrine neoplasia type 1","volume":"22","author":"Doherty","year":"1998","journal-title":"World J Surg."},{"key":"10.1016\/j.endonu.2010.10.011_bib0200","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1210\/jc.86.11.5282","article-title":"Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form","volume":"86","author":"Gibril","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2010.10.011_bib0205","first-page":"1043","article-title":"Pancreatic islet cell tumor metastasis in multiple endocrine neoplasia type 1: correlation with primary tumor size","volume":"125","author":"Lowney","year":"1999","journal-title":"Surgery."},{"key":"10.1016\/j.endonu.2010.10.011_bib0210","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.surg.2004.06.049","article-title":"The surgical management of MEN-1 pancreatoduodenal neuroendocrine disease","volume":"136","author":"Hausman","year":"2004","journal-title":"Surgery."},{"key":"10.1016\/j.endonu.2010.10.011_bib0215","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF01654904","article-title":"Thirty years\u2019 experience with gastrinoma","volume":"8","author":"Zollinger","year":"1984","journal-title":"World J Surg."},{"key":"10.1016\/j.endonu.2010.10.011_bib0220","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jso.20181","article-title":"Multiple endocrine neoplasia type 1","volume":"89","author":"Doherty","year":"2005","journal-title":"J Surg Oncol."},{"key":"10.1016\/j.endonu.2010.10.011_bib0225","first-page":"243","article-title":"Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma","volume":"94","author":"Shomanesh","year":"2002","journal-title":"Cancer."},{"key":"10.1016\/j.endonu.2010.10.011_bib0230","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1677\/erc.0.0100451","article-title":"Somatostatin receptors in gastroenteropancreatic neuroendocrine tumours","volume":"10","author":"De Herder","year":"2003","journal-title":"Endoc Relat Cancer."},{"key":"10.1016\/j.endonu.2010.10.011_bib0235","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00535-002-1170-8","article-title":"Octreotide in control of multiple liver metastases from gastrinoma","volume":"38","author":"Saijo","year":"2003","journal-title":"J Gastroenterol."},{"key":"10.1016\/j.endonu.2010.10.011_bib0240","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.beem.2004.09.001","article-title":"Nuclear medicine in the detection and management of pancreatic-cells tumours","volume":"19","author":"Virgolini","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"10.1016\/j.endonu.2010.10.011_bib0245","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1677\/erc.1.01200","article-title":"Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma","volume":"13","author":"Butturini","year":"2006","journal-title":"Endoc Relat Cancer."},{"key":"10.1016\/j.endonu.2010.10.011_bib0250","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/annonc\/mdj113","article-title":"Long term clinical outcome of somatostain analogues for the treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma","volume":"17","author":"Panzuto","year":"2006","journal-title":"Ann Oncol."},{"key":"10.1016\/j.endonu.2010.10.011_bib0255","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1200\/JCO.2003.12.142","article-title":"Prospective randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastropancreatic tumors","volume":"21","author":"Faiss","year":"2003","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.endonu.2010.10.011_bib0260","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1200\/JCO.2004.04.024","article-title":"Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastasic pancreatic endocrine carcinomas","volume":"22","author":"Kouvaraki","year":"2004","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.endonu.2010.10.011_bib0265","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.suc.2008.10.001","article-title":"The surgical and systemic management of neuroendocrine tumors of the pancreas","volume":"89","author":"Abood","year":"2009","journal-title":"Surg Clin N Am."},{"key":"10.1016\/j.endonu.2010.10.011_bib0270","series-title":"The parathyroids","first-page":"591","article-title":"Multiple endocrine neoplasia type 1: clinical features and management","author":"Metz","year":"1994"},{"key":"10.1016\/j.endonu.2010.10.011_bib0275","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2796.1995.tb00935.x","article-title":"Operative tumor yield obviates preoperative pancreatic tumor localization in MEN type 1","volume":"238","author":"Skogseid","year":"1995","journal-title":"J Int Med."}],"container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092210003074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092210003074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T06:17:35Z","timestamp":1637302655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1575092210003074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1575092210003074"],"URL":"https:\/\/doi.org\/10.1016\/j.endonu.2010.10.011","relation":{},"ISSN":["1575-0922"],"issn-type":[{"value":"1575-0922","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}